Bliss GVS Pharma Ltd (BLISSGVS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 730684, "name": "Bliss GVS Pharma", "stock_name": "Bliss GVS Pharma", "full_name": "Bliss GVS Pharma Ltd", "name_url": "stocks-analysis/bliss-gvs-pharma", "exchange": 0, "exchangecode": "", "country_id": 34, "currency": "INR", "cmp": "203.75", "chg": 20.25, "chgp": "11.04%", "dir": 1, "prev_price": "183.50", "mcapval": "2,041.00 Cr", "mcap": "Micro Cap", "scripcode": 506197, "symbol": "BLISSGVS", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "", "isin": "INE416D01022", "curr_date": "Feb 09", "curr_time": "", "bse_nse_vol": "95.93 lacs", "exc_status": "Active", "traded_date": "Feb 09, 2026", "traded_date_str": "2026 02 09", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bliss-gvs-pharma-730684-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Bliss GVS Pharma Ltd Hits New 52-Week High of Rs 200", "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-hits-new-52-week-high-of-rs-200-3828474", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BlissGVSPharmaL_priceRelatedfactors_3828474.png", "date": "2026-02-09 10:11:30", "description": "Bliss GVS Pharma Ltd has surged to a fresh 52-week high, touching Rs.200 today, reflecting robust momentum in the Pharmaceuticals & Biotechnology sector. This milestone underscores the stock’s strong performance over the past year, significantly outpacing broader market indices and sector peers." }, { "title": "When is the next results date for Bliss GVS Pharma Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-bliss-gvs-pharma-ltd-3821212", "imagepath": "", "date": "2026-02-04 23:16:57", "description": "The next results date for Bliss GVS Pharma Ltd is scheduled for 10 February 2026...." }, { "title": "Bliss GVS Pharma Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/bliss-gvs-pharma-ltd-is-rated-hold-3816374", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BlissGVSPharmaL_mojoScore_3816374.png", "date": "2026-02-02 10:10:04", "description": "Bliss GVS Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 February 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Bliss GVS Pharma Ltd Hits Intraday High with 7.54% Surge on 29 Jan 2026", "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-hits-intraday-high-with-754-surge-on-29-jan-2026-3809724", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BlissGVSPharmaL_priceRelatedfactors_3809724.png", "date": "2026-01-29 13:17:33", "description": "Bliss GVS Pharma Ltd demonstrated robust intraday performance on 29 Jan 2026, surging to an intraday high of Rs 178.65, marking a 7.54% increase from the previous close. The stock outperformed its sector and broader market indices, continuing its upward momentum amid positive trading activity." }, { "title": "Bliss GVS Pharma Ltd Falls 5.93%: 2 Key Factors Driving the Weekly Decline", "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-falls-593-2-key-factors-driving-the-weekly-decline-3803514", "imagepath": "", "date": "2026-01-24 16:01:27", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Jan 19:</strong> Sharp decline of 4.62% to Rs.164.20</p>\n <p><strong>Jan 20:</strong> Continued fall of 4.35% amid heavy volume</p>\n <p><strong>Jan 21:</strong> Mixed technical signals emerge as price dips further</p>\n <p><strong>Jan 22:</strong> Modest rebound of 0.78% to Rs.154.90</p>\n <p><strong>Jan 23:</strong> Intraday high surge of 7.13%, closing at Rs.161.95</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.172.15</div></div>\n <div class=\"stat-item\"><div c..." }, { "title": "Bliss GVS Pharma Ltd Hits Intraday High with 7.13% Surge on 23 Jan 2026", "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-hits-intraday-high-with-713-surge-on-23-jan-2026-3801614", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BlissGVSPharmaL_priceRelatedfactors_3801614.png", "date": "2026-01-23 10:56:36", "description": "Bliss GVS Pharma Ltd demonstrated robust intraday performance on 23 Jan 2026, surging to an intraday high of Rs 168, marking an 8.46% increase from previous levels. The stock outperformed its sector and broader market indices, reflecting strong trading momentum throughout the session." }, { "title": "Bliss GVS Pharma Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/bliss-gvs-pharma-ltd-is-rated-hold-3800041", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BlissGVSPharmaL_mojoScore_3800041.png", "date": "2026-01-22 10:10:04", "description": "Bliss GVS Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 Nov 2025. While the rating change occurred then, the analysis and financial metrics discussed here reflect the company’s current position as of 22 January 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Bliss GVS Pharma Ltd Sees Mixed Technical Signals Amid Price Momentum Shift", "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-sees-mixed-technical-signals-amid-price-momentum-shift-3797662", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BlissGVSPharmaL_technicaldot_3797662.png", "date": "2026-01-21 08:02:57", "description": "Bliss GVS Pharma Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from bullish to mildly bullish territory. Despite a recent decline in share price, the stock’s technical profile presents a complex picture, reflecting both resilience and caution for investors navigating the Pharmaceuticals & Biotechnology sector." }, { "title": "Bliss GVS Pharma Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/bliss-gvs-pharma-ltd-is-rated-hold-3788934", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BlissGVSPharmaL_mojoScore_3788934.png", "date": "2026-01-11 10:10:03", "description": "Bliss GVS Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance." } ], "total": 295, "sid": "730684", "stock_news_url": "https://www.marketsmojo.com/news/bliss-gvs-pharma-730684" }, "announcements": [ { "caption": "Board Meeting Intimation for The Meeting Board Of Directors Of The Company Is Scheduled To Be Held On Tuesday February 10 2026.", "datetime": "03-Feb-2026", "details": "Bliss GVS Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 inter alia to consider and approve 1. The Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31 2025. 2. The Interim Dividend if any for the financial year 2025-2026.", "source": "BSE" }, { "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report", "datetime": "30-Jan-2026", "details": "Please find enclosed herewith the Scrutinizer Report alongwith the Voting Results.", "source": "BSE" }, { "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot", "datetime": "30-Jan-2026", "details": "Please find enclosed herewith the Voting Result alongwith the Scrutinizer Report.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "10 Feb 2026" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Bliss GVS Pharma Ltd has declared <strong>50%</strong> dividend, ex-date: 24 Jul 25", "dt": "2025-07-24", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Bliss GVS Pharma Ltd has announced <strong>1:10</strong> stock split, ex-date: 11 Mar 08", "dt": "2008-03-11", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Bliss GVS Pharma Ltd has announced <strong>3:5</strong> bonus issue, ex-date: 26 Sep 08", "dt": "2008-09-26", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

Jan 19: Sharp decline of 4.62% to Rs.164.20

Jan 20: Continued fall of 4.35% amid heavy volume

Jan 21: Mixed technical signals emerge as price dips further

Jan 22: Modest rebound of 0.78% to Rs.154.90

Jan 23: Intraday high surge of 7.13%, closing at Rs.161.95

Week Open

Rs.172.15

Read full news article

Bliss GVS Pharma Ltd Hits Intraday High with 7.13% Surge on 23 Jan 2026

2026-01-23 10:56:36

Bliss GVS Pharma Ltd demonstrated robust intraday performance on 23 Jan 2026, surging to an intraday high of Rs 168, marking an 8.46% increase from previous levels. The stock outperformed its sector and broader market indices, reflecting strong trading momentum throughout the session.

Read full news article

Bliss GVS Pharma Ltd is Rated Hold

2026-01-22 10:10:04

Bliss GVS Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 Nov 2025. While the rating change occurred then, the analysis and financial metrics discussed here reflect the company’s current position as of 22 January 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Bliss GVS Pharma Ltd Sees Mixed Technical Signals Amid Price Momentum Shift

2026-01-21 08:02:57

Bliss GVS Pharma Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from bullish to mildly bullish territory. Despite a recent decline in share price, the stock’s technical profile presents a complex picture, reflecting both resilience and caution for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Bliss GVS Pharma Ltd is Rated Hold

2026-01-11 10:10:03

Bliss GVS Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article